| May 28 |
NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
|
| May 23 |
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
|
| May 23 |
Nanobiotix S.A. (NBTX) Q1 2024 Earnings Call Transcript
|
| May 22 |
Nanobiotix reports Q1 results
|
| May 22 |
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
|
| May 21 |
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
|
